eye care
J&J’s antihistamine-releasing contact lens shows promise in Phase 3 trials
March 28, 2019Research and Development J&J, JJ, eye care, pharma
Johnson and Johnson has unveiled new Phase 3 data on its antihistamine-releasing contact lens, showing that the investigational product led …
Janssen seals global inherited retinal disease partnership with gene therapy firm MeiraGTx
February 1, 2019Medical Communications, Research and Development, Sales and Marketing Janssen, MeiraGTx, eye care, gene therapy, pharma
In a bid to boost its portfolio in the eye care space, Janssen has announced a global partnership with clinical-stage …
Novartis eyecare unit Alcon to set up new HQ in Geneva, Switzerland
September 11, 2018Manufacturing and Production Alcon, Novartis, eye care, pharma
Alcon, the eyecare unit of Novartis, is set to move to a new home next year, after its parent company …
Novartis spins off Alcon as CEO focuses drug search
June 29, 2018Medical Communications, Sales and Marketing Alcon, Novartis, eye care, pharma
Novartis has announced a plan to spinoff Alcon – its eye care division – into a separately-traded standalone company.Novartis has …
Allergan set to acquire eye-care biotech ForSight VISION5
August 12, 2016Medical Communications, Sales and Marketing Allergan, ForSight VISION5, acquisition, biotech, eye care
Allergan has announced its acquisition of privately-held, clinical-stage eye-care biotech ForSight VISION5 for a $95 million upfront payment and a …
Allergan breaks ground on $200 million expansion at Texas site
April 26, 2016Manufacturing and Production Allergan, doubling, expansion, eye care, facility, investment, manufacturing, size, texas, waco
Allergan (NYSE: AGN) has broken ground on a $200 million expansion at its manufacturing facility in Waco, Texas. The expansion …
Merck acquires eyecare specialist Inspire
April 6, 2011Research and Development, Sales and Marketing Inspire, Merck, eye care
Merck & Co is to buy ophthalmic specialist Inspire Pharmaceuticals in a $430 million deal which sees it move further …
Novartis becomes global eye health leader as Alcon deal finalised
December 15, 2010Manufacturing and Production, Research and Development, Sales and Marketing Alcon, Lucentis, Novartis, eye care, eye health, ophthalmology
Novartis’ 11-month standoff with Alcon shareholders has ended, allowing it to acquire all the remaining shares in the ophthalmology firm. …
Eye treatment could be commercial breakthrough for ThromboGenics
September 1, 2010Research and Development ThromboGenics, eye care, microplasmin
Belgian biopharma company ThromboGenics could have a major product on its hands in the shape of new eye treatment. The …
Novartis to acquire majority stake in Alcon
January 5, 2010Sales and Marketing Alcon, Novartis, eye care
Novartis plans to gain a majority hold of global eye care leader Alcon, significantly boosting its presence in the sector. …
